Quick navigation menu :

  1. Go to the content
  2. Go to the main sections menu
  3. Go to the search engine
  4. Go to the languages menu
  5. Go to the help menu
  6. Go to the modules
  7. Go to the shortcuts list

Help menu :

  1. Sanofi Worldwide |
  2. Canadian Web Sites |
  3. Global Business Websites |
  4. Contact us |
  5. Sitemap |
  6. Help
  1. RSS
  2. Font size

    Reduce font size Increase font size  

Media Room

Contact us

Sanofi Canada

2905 Place Louis-R.-Renaud
Laval, Quebec, H7V 0A3

Media inquiries

Toll-free: 1-877-904-2667

Stephanie Weinstein
Corporate Communications, Sanofi Canada
(514) 799-7184
Email: Stephanie.weinstein@sanofi.com

Maggie Wang Maric
Head of Communications | Sanofi Pasteur Canada
Media Line: (416) 667-2620
Email: Maggie.wangmaric@sanofi.com

General inquiries


Press Releases

Archives: Search / 2018 / 2017 / 2016 / 2015 / 2014 / 2013


2018 Archives

Oct 17, 2018

Sanofi Canada is on a mission to raise awareness and money to help people living with diabetes, one of the leading causes of death and disability in Canada.1 In honor of Diabetes Awareness Month,...

Oct 1, 2018

Influenza has a significant human and economic impact due to the burden of illness and high number of hospitalizations. With the majority of these in seniors,i the impact on them and their...

Sep 27, 2018

Source: Sanofi (EURONEXT: SAN) (NYSE: SNY) * Toujeo® receives provincial formulary coverage in Ontario * Lantus® gains improved provincial formulary coverage in Manitoba LAVAL, QC, Sept. 27,...

Sep 25, 2018
Studies show that Lovenox® (enoxaparin sodium) is an alternative to conventional heparin in preventing clotting during hemodialysis

Laval, Quebec – September 25, 2018 – Sanofi Canada announced today Health Canada’s approval of a new indication for Lovenox® (enoxaparin sodium) for the prevention of thrombus formation in...

Jul 10, 2018

Source: Sanofi (EURONEXT: SAN) (NYSE: SNY) * CADTH recommendation for Dupixent™ disregards patient input and ignores clinical value LAVAL, QC, July 10, 2018 /CNW Telbec/ - Sanofi Genzyme is...

Jul 3, 2018

July 3, 2018, Toronto, ON – The Canadian Association of Radiation Oncology (CARO) and Sanofi Canada are pleased to announce three CARO members have been awarded the Sanofi-CARO Awards! $20,000...

Jun 27, 2018

Toujeo® (insulin glargine injection 300 Units/mL) met primary endpoint in lowering blood sugar levels and was non-inferior to insulin degludec in adults with type 2 diabetes not previously on...

Jun 22, 2018

For Canadian media only Laval, Quebec - Sanofi Canada is proud to support the health and well-being of Canadians. In collaboration with Health Canada, we are bringing life-saving treatment to help...

Jun 13, 2018

Source: Sanofi (EURONEXT: SAN) (NYSE: SNY) Three-quarters of employers are worried about the impact of unmanaged chronic disease Two-thirds (66%) of Canadian employees would consent to receive...

Jun 8, 2018

Sajeev Kohli, a Grade 11 student from Waterloo, Ontario, receives top honours in the Global Healthcare Challenge LAVAL, QC, June 7, 2018 /CNW Telbec/ - Sajeev Kohli, a grade 11 student science...

May 16, 2018

Sanofi and Sun Life Financial are pleased to announce a new program that provides Canadians living with diabetes access to health information related to the use of Sanofi's Toujeo insulin pen....

Apr 12, 2018

Source: Sanofi (EURONEXT: SAN) (NYSE: SNY) Expansion demonstrates company's commitment to innovation and leadership in global public health New Toronto facility is one of the largest-ever...

Apr 12, 2018

* Panel of Canadian experts recommend new ways to overcome barriers Canadians face when trying to achieving their target glucose (blood sugar) levels.1 LAVAL, QC, April 12, 2018 /CNW Telbec/ -...

Apr 11, 2018

Sanofi invites members of the media to the announcement of a landmark investment in lifesaving vaccine production in Canada. The investment will cement the company's Canadian operations as a key...

Apr 10, 2018

Sanofi invites members of the media to the announcement of a landmark investment in lifesaving vaccine production in Canada. The investment will cement the company's Canadian operations as a key...

Mar 10, 2018

ODYSSEY OUTCOMES trial met its primary endpoint, demonstrating that high-risk patients who added Praluent® (alirocumab) to maximally-tolerated statins experienced significantly fewer major...

Feb 23, 2018
Sanofi Canada donates nearly $40,000 to Centraide of Greater Montreal as 2017 Season of Solidarity campaign comes to an end

Laval, February 23, 2018 - Sanofi Canada congratulates Centraide of Greater Montreal for its remarkable success in its 2017 fundraising campaign, proudly contributing $39,389 and donating...


Corporate information